Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 208-210
DOI: 10.4103/0971-5851.123745
ORIGINAL ARTICLE

Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009

Senthil Rajappa
Department of Medical Oncology, Nizam′s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
,
Lalit Varadpande
Department of Medical Oncology, Nizam′s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
,
Tara Roshni Paul
Department of Medical Oncology, Nizam′s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
,
Rachel Thomas Jacob
Department of Medical Oncology, Nizam′s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
,
Raghunadharao Digumarti
Department of Medical Oncology, Nizam′s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Nizam′s Institute of Medical Science is a premier institute of Hyderabad, established in 1980. The Medical Oncology Unit is the 1 st comprehensive cancer center established for the state of Andhra Pradesh. The department has presented a data of total 201 patients with the median age of 32 at diagnosis. Among these 66 (33%) patients belonged to low Hasford risk group. Complete hematologic response was seen in 195 (97%) of patients. The progression free survival (PFS) was 77% for all patients while those who achieved complete cytogenetic response, PFS was 88% at 29 months.

Keywords

Chronic myeloid leukemia - chronic phase - imatinib


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol 2002;19:141-50.
  • 2 Rajappa S, Varadpande L, Paul T, Jacob R, Digumarti R. Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country. Leuk Lymphoma 2008;49:554-8.
  • 3 Redaelli A, Bell C, Casagrande J, Stephens J, Botteman M, Laskin B, et al. Clinical and epidemiologic burden of chronic myelogenous leu kemia. Expert Rev Anticancer Ther 2004;4:85-96.
  • 4 Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000;111:993-1009.